AlzBiomarker
Alzheimer's Disease vs Control: MCP-1 (CSF)
Meta-analysis Results: Levels of MCP-1, a chemokine also known as C-C motif chemokine 2, appeared slightly elevated in the cerebrospinal fluid of people with Alzheimer’s disease and controls (effect size = 1.123). The effect was significant (p < 0.0001); however, the meta-analysis was limited to three eligible comparisons.

